Home > Quotes > IPXL
IPXL

Impax Laboratories, Inc. Common Stock Quote & Summary Data

$33.13
*  
0.22
0.66%
Get IPXL Alerts
*Delayed - data as of May 2, 2016  -  Find a broker to begin trading IPXL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    IPXL Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Impax Laboratories, Inc. Common Stock Intraday Chart




News for IPXL

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 33.76 $ 51.42
Low $ 32.80 $ 29.66

The current last sale of $33.13 is 11.70% Higher thanthe 52 week low.

P/E Ratio

ETFs with IPXL as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
3.36% PowerShares S&P SmallCap Health Care Portfolio (PSCH) -2.48 (-3.45%)
0.93% Vanguard S&P Small-Cap 600 Growth ETF (VIOG) -4.37 (-3.93%)
0.83% SPDR S&P 600 Small Cap Growth ETF (based on S&P SmallCap 600 G (SLYG) -14.62 (-7.78%)
0.83% iShares S&P SmallCap 600 Growth ETF (IJT) -5.15 (-3.97%)
0.47% Vanguard S&P Small-Cap 600 ETF (VIOO) -1.58 (-1.51%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a specialty pharmaceutical company applying formulation and development expertise, as well as our drug delivery technology, to the development, manufacture and marketing of bioequivalent pharmaceutical products, commonly referred to as "generics," in addition to the development and marketing of branded products. We operate in two segments, referred to as "Impax Generics" and "Impax Specialty Pharma". The Impax Generics division concentrates its efforts on the development, manufacture, sale and distribution of our generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are usually marketed under their established nonproprietary drug names rather than by a brand name.  ... More ...  

Risk Grade

Where does IPXL fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?